Skip to main content

Table 4 Median values and ranges of tumor volume, edema volume, necrosis volume, ADC, and rCBV ratio measurements before and after SRS across Follow-up intervals

From: Temporal evolution of MRI findings and survival outcomes in patients with brain metastases after stereotactic radiosurgery

Measurement

Pre-Treatment

1–3 months

3–8 months

8–16 months

16–24 months

*Tumor Volume (cm³)

0.351 (0.01–35.86)

0.19 (0.02–8.86)

0.14 (0–72.73)

0.18 (0–39.67)

0.22 (0–47.70)

*Edema Volume (cm³)

0.69 (0–129.29)

0.1 (0–199.42)

0 (0–275.27)

0.1 (0–142.97)

0 (0–246.58)

Necrosis Volume (cm³)

0 (0–17.67)

0 (0–16.12)

0.001 (0–9.71)

0 (0–19.77)

0 (0–22.22)

ADC (µm²/s)

0.85 (0.61–1.30)

0.91 (0.57–1.64)

0.91 (0.57–1.52)

0.94 (0.61–1.65)

0.95 (0.52–1.82)

rCBV Ratio

2.22 (0.76–13.14)

1.66 (0.71–5.51)

1.24 (0.15–5.68)

1.53 (0.5–22)

1.42 (0.32–25.5)

  1. * Statistically significant differences were observed in pairwise comparisons (p < 0.05)